Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy (DAPT) Study

Back

ESC Premium Access

Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy (DAPT) Study

Session: Clinical Trial Update Platelet therapy

Topic: Adjunctive medical therapy

Speaker: Doctor C. Resor (Boston, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Charles Resor

Brigham and Women's Hospital, Boston (United States of America)

1 presentation

0 follower

5 more presentations in this session

Prevention of First Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54

Speaker: Doctor M. Bonaca (Aurora, US)

Access

Slides

Video

The Italic/Italic Plus Trial

Speaker: Professor M. Gilard (Brest, FR)

Access

Slides

Video

PCI for Elderly patients at High Bleeding Risk. A substudy of the LEADERS FREE trial

Speaker: Doctor M. Morice (Massy, FR)

Access

Slides

Video

Ten-year outcomes of first-generation drug-eluting stents results of the sirolimus-eluting versus paclitaxel-eluting stents for coronary revascularization (SIRTAX) VERY LATE Trial

Speaker: Professor L. Raber (Bern, CH)

Access

Slides

Video

Ad-hoc versus non-ad-hoc percutaneous coronary intervention strategies in patients with stable coronary artery disease.

Speaker: Doctor T. Toyota (Kobe, JP)

Access

Slides

Video

Access the full session

Clinical Trial Update Platelet therapy

Speakers: Doctor C. Resor, Doctor M. Bonaca, Professor M. Gilard, Doctor M. Morice, Professor L. Raber...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources